Paper · 39227612
SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation.
Chen Z and 4 others. Sci Rep, 2024. Cited by 7 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation. Papers, record 39227612. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39227612
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Proliferation | Major topic |
| NF-kappa B | Major topic |
| Signal Transduction | Major topic |
| Thyroid Neoplasms | Major topic |
| Animals | |
| Female | |
| Humans | |
| Male | |
| Mice | |
| Middle Aged | |
| Cell Line, Tumor | |
| Gene Expression Regulation, Neoplastic | |
| Prognosis | |
| Thyroid Cancer, Papillary | |
| Tumor Microenvironment | |
| Repressor Proteins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022J01120919 | Fujian Natural Science Foundation Program | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34,057,118 | Overexpression of NF-kB as a predictor of neoadjuvant chemotherapy response in breast cancer. | Breast Dis | 2021 | https://conductscience.org/library/papers/34057118 | PubMed |
| 2 | 35,220,887 | Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis. | Gut Microbes | 2022 | https://conductscience.org/library/papers/35220887 | PubMed |
| 3 | 19,156,774 | Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma. | J Pathol | 2009 | https://conductscience.org/library/papers/19156774 | PubMed |
| 4 | 18,177,721 | The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. | Cell Metab | 2008 | https://conductscience.org/library/papers/18177721 | PubMed |
| 5 | 31,097,454 | Inhibiting BRAF Oncogene-Mediated Radioresistance Effectively Radiosensitizes BRAFV600E-Mutant Thyroid Cancer Cells by Constraining DNA Double-Strand Break Repair. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31097454 | PubMed |
| 6 | 30,874,331 | The Sprouty/Spred family as tumor suppressors: Coming of age. | Cancer Sci | 2019 | https://conductscience.org/library/papers/30874331 | PubMed |
| 7 | 33,276,434 | NF-κB and Disease. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33276434 | PubMed |
| 8 | 32,409,139 | NF-κB in the New Era of Cancer Therapy. | Trends Cancer | 2020 | https://conductscience.org/library/papers/32409139 | PubMed |
| 9 | 31,816,325 | HMGB1 upregulates NF-kB by inhibiting IKB-α and associates with diabetic retinopathy. | Life Sci | 2020 | https://conductscience.org/library/papers/31816325 | PubMed |
| 10 | 32,046,099 | Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32046099 | PubMed |
1 to 10 of 38
See all 38 referencesCited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,698,456 | Investigating the impact of Sprouty-related EVH1 domain-containing protein 3 on gastric cancer prognosis and tumor microenvironments. | Front Oncol | 2026 | https://conductscience.org/library/papers/42698456 | PubMed |
| 41,984,095 | Aryl hydrocarbon receptor orchestrates transcriptomic, non-coding and splicing programs that drive human lung epithelial responses to vaporized cannabis in vitro. | Arch Toxicol | 2026 | https://conductscience.org/library/papers/41984095 | PubMed |
| 41,369,405 | Extracellular Vesicles from iPSC-Derived Glial Progenitor Cells Prevent Glutamate-Induced Excitotoxicity by Stabilising Calcium Oscillations and Mitochondrial Depolarisation. | Cells | 2025 | https://conductscience.org/library/papers/41369405 | PubMed |
| 41,158,264 | Development and validation of a necroptosis-related gene signature for predicting prognosis and immune infiltration in papillary thyroid cancer. | Transl Cancer Res | 2025 | https://conductscience.org/library/papers/41158264 | PubMed |
| 41,068,688 | Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinoma. | BMC Cancer | 2025 | https://conductscience.org/library/papers/41068688 | PubMed |
| 40,806,788 | Loss of SPRED3 Causes Primary Hypothyroidism and Alters Thyroidal Expression of Autophagy Regulators LC3, p62, and ATG5 in Mice. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40806788 | PubMed |
| 40,596,746 | Global Thyroid Cancer Patterns and Predictive Analytics: Integrating Machine Learning for Advanced Diagnostic Modelling. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/40596746 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| NFKB1 | 4,790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| SPRED3 | 399,473 | PubTator's text mining | https://conductscience.org/library/genes/399473 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39227612
GET https://conductscience.org/api/papers/v1/39227612/references?page=2